RCEL
Price
$6.69
Change
-$0.32 (-4.56%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
399.48M
84 days until earnings call
TWST
Price
$29.52
Change
-$2.77 (-8.58%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
1.98B
79 days until earnings call
Ad is loading...

RCEL vs TWST

Header iconRCEL vs TWST Comparison
Open Charts RCEL vs TWSTBanner chart's image
Avita Medical
Price$6.69
Change-$0.32 (-4.56%)
Volume$4.93K
Capitalization399.48M
Twist Bioscience
Price$29.52
Change-$2.77 (-8.58%)
Volume$38.08K
Capitalization1.98B
RCEL vs TWST Comparison Chart
Loading...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCEL vs. TWST commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCEL is a Hold and TWST is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (RCEL: $7.01 vs. TWST: $32.29)
Brand notoriety: RCEL and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RCEL: 209% vs. TWST: 92%
Market capitalization -- RCEL: $399.48M vs. TWST: $1.98B
RCEL [@Medical Specialties] is valued at $399.48M. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCEL’s FA Score shows that 0 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • RCEL’s FA Score: 0 green, 5 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, TWST is a better buy in the long-term than RCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCEL’s TA Score shows that 5 TA indicator(s) are bullish while TWST’s TA Score has 4 bullish TA indicator(s).

  • RCEL’s TA Score: 5 bullish, 5 bearish.
  • TWST’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TWST is a better buy in the short-term than RCEL.

Price Growth

RCEL (@Medical Specialties) experienced а -23.89% price change this week, while TWST (@Medical Specialties) price change was -1.40% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.18%. For the same industry, the average monthly price growth was +4.70%, and the average quarterly price growth was +0.88%.

Reported Earning Dates

RCEL is expected to report earnings on Aug 07, 2025.

TWST is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Specialties (+1.18% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($1.98B) has a higher market cap than RCEL($399M). TWST YTD gains are higher at: -30.514 vs. RCEL (-45.234). RCEL has higher annual earnings (EBITDA): -33.54M vs. TWST (-172.41M). TWST has more cash in the bank: 311M vs. RCEL (89.1M). RCEL has less debt than TWST: RCEL (42.4M) vs TWST (91.9M). TWST has higher revenues than RCEL: TWST (262M) vs RCEL (50.1M).
RCELTWSTRCEL / TWST
Capitalization399M1.98B20%
EBITDA-33.54M-172.41M19%
Gain YTD-45.234-30.514148%
P/E RatioN/AN/A-
Revenue50.1M262M19%
Total Cash89.1M311M29%
Total Debt42.4M91.9M46%
FUNDAMENTALS RATINGS
RCEL vs TWST: Fundamental Ratings
RCEL
TWST
OUTLOOK RATING
1..100
5352
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
8787
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1895

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (43) in the Biotechnology industry is in the same range as RCEL (65) in the null industry. This means that TWST’s stock grew similarly to RCEL’s over the last 12 months.

TWST's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that TWST’s stock grew similarly to RCEL’s over the last 12 months.

TWST's SMR Rating (94) in the Biotechnology industry is in the same range as RCEL (99) in the null industry. This means that TWST’s stock grew similarly to RCEL’s over the last 12 months.

TWST's Price Growth Rating (87) in the Biotechnology industry is in the same range as RCEL (87) in the null industry. This means that TWST’s stock grew similarly to RCEL’s over the last 12 months.

TWST's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that TWST’s stock grew similarly to RCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCELTWST
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 17 days ago
74%
Bullish Trend 21 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFEIX14.07N/A
N/A
Nuveen Dividend Value A
GREAX11.29N/A
N/A
Goldman Sachs Real Estate Securities A
SMEYX15.66N/A
N/A
Invesco Small Cap Equity Y
PEQLX35.57N/A
N/A
Putnam Large Cap Value R5
IYSMX16.22N/A
N/A
Macquarie Smid Cap Core Fund Class R

TWST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TWST has been loosely correlated with VCYT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TWST jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TWST
1D Price
Change %
TWST100%
-2.00%
VCYT - TWST
51%
Loosely correlated
-4.71%
ALGN - TWST
49%
Loosely correlated
+0.75%
GH - TWST
49%
Loosely correlated
-0.72%
RVTY - TWST
47%
Loosely correlated
-1.82%
ILMN - TWST
47%
Loosely correlated
+5.99%
More